US biopharming business sets off new GM contamination episode
The biotechnology industry was immersed in a new controversy in November when the first incidents involving contamination of food crops by plants which had been genetically modified to produce pharmaceuticals came to light in the US. The affair has set biotech businesses against food manufacturers and underlined the huge difficulties ahead in safeguarding the food chain as the GM revolution advances.
Sorry you do not have access to this article. Please contact Customer Support at
or call 020 8267 8120